Marksans Pharma’s arm receives marketing authorization

25 Feb 2025 Evaluate

Marksans Pharma’s wholly owned subsidiary in UK -- Relonchem has received Marketing Authorization for the product Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets (Bell's Healthcare Dual Action Pain Relief 200 mg/500 mg Film-coated Tablets). 

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.


Marksans Pharma Share Price

172.90 0.65 (0.38%)
19-Jan-2026 14:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1684.00
Dr. Reddys Lab 1175.05
Cipla 1393.30
Zydus Lifesciences 872.95
Lupin 2179.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×